Torsemide Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 20 mg, 100 mg
Reference Brands: Demadex(US & EU)
Category:
Heart Disorder
Torsemide is a loop diuretic that inhibits the sodium-potassium-chloride co-transporter in the kidneys, increasing urine production. It effectively reduces fluid buildup, edema, and blood pressure. Benefits include rapid symptom relief, improved heart and kidney function, enhanced fluid control, and better management of heart failure and hypertension.
Torsemide tablets is available in Tablet
and strengths such as 10 mg, 20 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Torsemide tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Torsemide tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Torsemide tablets, marketed as Demadex, are approved in the US by the FDA and in the EU via EMA for edema and hypertension management. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier submission, regulatory pathways, and market access strategies, visit PharmaTradz. Proper regional compliance supports timely approval, safe use, and global availability of torsemide tablets, enabling effective treatment of fluid retention and cardiovascular conditions worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing